Old Web
English
Sign In
Acemap
>
authorDetail
>
Ch. Thomssen
Ch. Thomssen
Goethe University Frankfurt
Medicine
Metastatic breast cancer
Immunology
Epirubicin
Oncology
3
Papers
57
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial.
2004
European Journal of Cancer
Michael Untch
Holger Eidtmann
A du Bois
H. G. Meerpohl
Ch. Thomssen
A Ebert
Nadia Harbeck
C. Jackisch
V Heilman
Günter Emons
D. Wallwiener
Wiese W
Ju Blohmer
K. Höffken
Walther Kuhn
Peter Reichardt
M. Muscholl
M Pauschinger
B. Langer
H.-J. Lück
Show All
Source
Cite
Save
Citations (55)
Phase III trial comparing epirubicin/paclitaxel vs epirubicin/cyclophosphamid as first line treatment in metastatic breast cancer: Preliminary results of a German AGO trial
1998
European Journal of Cancer
G. von Minckwitz
W. Kuhn
Ch. Thomssen
M. Untch
Th. Bauknecht
D. Eidtmann
V. Möbus
A. du Bois
H.-J. Lück
Show All
Source
Cite
Save
Citations (1)
PP-7-5 phase II study of paclitaxel (P) and eplrubicin (E) as first-line therapy in patients (PTS) with metastatic breast cancer (MBC)
1996
European Journal of Cancer
Ch. Thomssen
H.-J. Lück
A du Bois
B. Lisboa
Michael Untch
Köhler G
Hecker D
K. Diergarten
Show All
Source
Cite
Save
Citations (1)
1